An expert committee of APPCB has pointed out the presence of unapproved products in samples of 15 drug and pharmaceutical manufacturing units. The findings were part of a report sought by the Appellate Authority under the Water (Prevention and Control of Pollution) Act and the Air (Prevention and Control of Pollution) Act, with respect to an appeal filed by 18 drug and pharmaceutical manufacturing units.

The report has mentioned that the products were other than those permitted under Consent For Establishment and Consent For Operation given by the APPCB.